Epithelial ovarian tumors of borderline malignancy: long-term follow-up
- PMID: 8406194
- DOI: 10.1006/gyno.1993.1218
Epithelial ovarian tumors of borderline malignancy: long-term follow-up
Abstract
Thirty-nine patients underwent primary surgery for epithelial ovarian tumors of low malignant potential at the Massachusetts General Hospital between 1970 and 1980. Eighty-five percent of patients were found to have Stage I disease and 15% were found to have Stage III disease. Fifty-four percent of patients had a tumor with serous histology, 39% had a tumor with mucinous histology, and the remainder of patients had tumors with an endometrioid or mixed-cell type. Second malignancies and benign ovarian tumors were frequently found concomitantly with the borderline tumors or in follow-up. Gastrointestinal and endometrial adenocarcinomas were the most common second malignancies and were frequently found associated with a borderline tumor of serous histology. Follow-up was available in all 39 patients (100%). Mean time of follow-up was 11.8 years. Sixty-nine percent of patients are clinically without evidence of disease with a mean follow-up of 14.7 years, 23% died of other causes, 5% died of disease, and 3% died with disease and sepsis. All patients dying with disease did so within 7.3 years of their primary surgery. Seven patients underwent conservative surgery, defined as preservation of some ovarian tissue. Six of 7 patients are clinically free of disease with a mean follow-up of 14.6 years; 1 patient died of other causes. No patients treated conservatively had a recurrence of their disease.
Similar articles
-
The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.Am J Surg Pathol. 2006 Nov;30(11):1367-71. doi: 10.1097/01.pas.0000213294.81154.95. Am J Surg Pathol. 2006. PMID: 17063075
-
Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.Cancer. 1996 Jul 15;78(2):278-86. doi: 10.1002/(SICI)1097-0142(19960715)78:2<278::AID-CNCR14>3.0.CO;2-T. Cancer. 1996. PMID: 8674004
-
Endometrial cancer in premenopausal women 45 years and younger.Obstet Gynecol. 1995 Apr;85(4):504-8. doi: 10.1016/0029-7844(95)00001-8. Obstet Gynecol. 1995. PMID: 7898824
-
Management of epithelial ovarian tumors of low malignant potential.Gynecol Oncol. 1994 Dec;55(3 Pt 2):S52-61. doi: 10.1006/gyno.1994.1342. Gynecol Oncol. 1994. PMID: 7835812 Review.
-
Epithelial ovarian tumors in children: a retrospective analysis.J Pediatr Surg. 2003 Mar;38(3):331-5; discussion 331-5. doi: 10.1053/jpsu.2003.50103. J Pediatr Surg. 2003. PMID: 12632344 Review.
Cited by
-
Borderline epithelial tumors of the ovary: Experience of 55 patients.Oncol Lett. 2015 Feb;9(2):912-914. doi: 10.3892/ol.2014.2758. Epub 2014 Dec 2. Oncol Lett. 2015. PMID: 25621067 Free PMC article.
-
Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential.Br J Cancer. 2004 Mar 22;90(6):1204-10. doi: 10.1038/sj.bjc.6601681. Br J Cancer. 2004. PMID: 15026802 Free PMC article.
-
Outcomes of controlled ovarian hyperstimulation/in vitro fertilization for infertile patients with borderline ovarian tumor after conservative treatment.J Korean Med Sci. 2007 Sep;22 Suppl(Suppl):S134-8. doi: 10.3346/jkms.2007.22.S.S134. J Korean Med Sci. 2007. PMID: 17923740 Free PMC article.
-
Ultraconservative, Fertility Sparing Treatment of Bilateral Borderline Ovarian Tumors: A Case Report of a 26-Year-Old, 0-Gravida with an Endometrioid Borderline Ovarian Tumor of the Right Ovary and a Sero-Mucinous Borderline Ovarian Tumor of the Left Ovary and a Review of the Literature.Int J Womens Health. 2020 Aug 6;12:601-611. doi: 10.2147/IJWH.S258478. eCollection 2020. Int J Womens Health. 2020. PMID: 32821173 Free PMC article.
-
Invasive recurrence of serous borderline ovarian tumor as multifocal lymphadenopathy 25 years after initial diagnosis.Gynecol Oncol Case Rep. 2012 Aug 28;2(4):136-8. doi: 10.1016/j.gynor.2012.08.002. eCollection 2012. Gynecol Oncol Case Rep. 2012. PMID: 24371646 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical